Sanne de Bruin

73 Transfusion practice in the bleeding critically ill; an international online survey – The TRACE-2 Survey 17. Mesar T, Larentzakis A, Dzik W, Chang Y, Velmahos G, Yeh DD. Association between ratio of fresh frozen plasma to red blood cells during massive transfusion and survival among patients without traumatic injury. JAMA Surg. 2017;152(6):574–80. 18. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (London, England) [Internet]. 2010 Jul 3;376(9734):23–32. Available from: http://dx.doi.org/10.1016/S0140- 6736(10)60835-5 19. Shakur H, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, Akintan A, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16. 20. Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Brenner A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10241):1927–36. 21. BaharogluMI, Cordonnier C, Salman RAS, de Gans K, KoopmanMM, Brand A, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet [Internet]. 2016;387(10038):2605–13. Available from: http://dx.doi.org/10.1016/S0140-6736 (16)30392-0 22. Hajjar LA, Vincent J-L, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA [Internet]. 2010 Oct 13;304(14):1559–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20940381 23. Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, et al. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery. N Engl J Med. 2017;377(22):2133–44. 24. National Institute for Health and Care Excellence. Blood Transfusion [Internet]. Blood Transfusion. 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25520986%5Cnhttp: //www.ncbi.nlm. nih.gov/pubmed/26632625 25. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA [Internet]. 2016 Nov 15;316(19):2025–35. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001 / jama.2016.9185 26. Martucci G, Grasselli G, Tanaka K, Tuzzolino F, Panarello G, Schmidt M, et al. Hemoglobin trigger and approach to red blood cell transfusions during veno-venous extracorporeal membrane oxygenation: the international TRAIN-ECMO survey. Perfusion [Internet]. 2019;34(1_suppl):39–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30966906 27. Crochemore T, Corrêa TD, Lance MD, Solomon C, Neto AS, De Campos Guerra JC, et al. Thromboelastometry profile in critically ill patients: A single-center, retrospective, observational study. PLoS One. 2018;13(2):1–14. 28. Sarode R. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence. Clin Lab Med [Internet]. 2014 Sep;34(3):613–21. Available from: http://dx.doi.org/10.1016/S0140-6736 (14)61685-8 3